BRPI0815889A2 - Análise do perfil de glicosilação. - Google Patents

Análise do perfil de glicosilação.

Info

Publication number
BRPI0815889A2
BRPI0815889A2 BRPI0815889-4A2A BRPI0815889A BRPI0815889A2 BR PI0815889 A2 BRPI0815889 A2 BR PI0815889A2 BR PI0815889 A BRPI0815889 A BR PI0815889A BR PI0815889 A2 BRPI0815889 A2 BR PI0815889A2
Authority
BR
Brazil
Prior art keywords
profile analysis
glycosylation profile
glycosylation
analysis
profile
Prior art date
Application number
BRPI0815889-4A2A
Other languages
English (en)
Inventor
Markus Haberger
Dietmar Reusch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0815889A2 publication Critical patent/BRPI0815889A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
BRPI0815889-4A2A 2007-08-31 2008-08-20 Análise do perfil de glicosilação. BRPI0815889A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07017063 2007-08-31
PCT/EP2008/006835 WO2009027041A1 (en) 2007-08-31 2008-08-20 Glycosylation profile analysis

Publications (1)

Publication Number Publication Date
BRPI0815889A2 true BRPI0815889A2 (pt) 2014-10-14

Family

ID=38596692

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815889-4A2A BRPI0815889A2 (pt) 2007-08-31 2008-08-20 Análise do perfil de glicosilação.

Country Status (12)

Country Link
US (1) US20110117601A1 (pt)
EP (1) EP2188382A1 (pt)
JP (1) JP2010536355A (pt)
KR (1) KR20100038235A (pt)
CN (1) CN101784670A (pt)
AU (1) AU2008291358A1 (pt)
BR (1) BRPI0815889A2 (pt)
CA (1) CA2697091A1 (pt)
IL (1) IL202566A0 (pt)
RU (1) RU2010112236A (pt)
TW (1) TW200916585A (pt)
WO (1) WO2009027041A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012032203A (ja) * 2010-07-29 2012-02-16 Sumitomo Bakelite Co Ltd 抗体の糖鎖を調製する方法
EP2616809B1 (en) * 2010-09-17 2017-04-05 Prozyme, Inc. Isolation and deglycosylation of glycoproteins
JP5990000B2 (ja) * 2011-01-31 2016-09-07 公益財団法人野口研究所 Ｍａｌｄｉ質量分析法用測定試料調製方法
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US10221210B2 (en) * 2011-07-20 2019-03-05 Zepteon, Incorporated Polypeptide separation methods
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9169331B2 (en) * 2012-12-21 2015-10-27 Dionex Corporation Separation of glycans by mixed-mode liquid chromatography
US9310344B2 (en) 2013-06-14 2016-04-12 Dionex Corporation HILIC/anion-exchange/cation-exchange multimodal media
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
TWI670279B (zh) * 2013-03-15 2019-09-01 美商艾爾德生物製藥股份有限公司 抗體純化及純度監測
GB201315705D0 (en) * 2013-09-04 2013-10-16 Univ Dublin Methods for predicting, diagmosing or monitoring infections
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
TWI793159B (zh) 2013-10-23 2023-02-21 美商健臻公司 重組醣蛋白及其用途
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN103983684B (zh) * 2014-04-14 2016-08-17 南昌大学 一种高效的maldi板上的糖基化抑制剂筛选方法
JP6750148B2 (ja) * 2014-04-25 2020-09-02 公益財団法人野口研究所 糖鎖切断抗体の製造方法及び均一糖鎖抗体
CN106459118B (zh) * 2014-04-30 2019-09-24 贝克曼考尔特公司 聚糖样品制备
KR20170012286A (ko) * 2014-05-30 2017-02-02 뉴 잉글랜드 바이오랩스, 인크 탈당화 시약 및 방법
EP2975401B1 (en) * 2014-07-18 2019-12-25 Hexal AG Improved method of mapping glycans of glycoproteins in serum samples
JP6344117B2 (ja) * 2014-07-25 2018-06-20 株式会社島津製作所 磁性ビーズを用いた糖鎖又は糖ペプチドの精製濃縮方法
WO2016061065A1 (en) * 2014-10-15 2016-04-21 Alexion Pharmaceuticals, Inc. Methods of shifting an isoelectric profile of a protein product and uses thereof
ES2949063T3 (es) * 2015-05-18 2023-09-25 Univ California Sistemas y métodos para predecir la glucosilación de proteínas
CN105277718B (zh) * 2015-09-29 2018-03-20 上海知先生物科技有限公司 用于恶性肿瘤相关筛查及评估的产品、应用及方法
EP3497444A4 (en) 2016-08-12 2020-11-11 Abreos Biosciences, Inc. DETECTION AND QUANTIFICATION OF NATALIZUMAB
MX2019006266A (es) * 2016-12-21 2019-08-21 Hoffmann La Roche Glucomanipulacion in vitro de anticuerpos.
CN117887794A (zh) 2016-12-21 2024-04-16 豪夫迈·罗氏有限公司 用于体外糖工程化抗体的方法
AU2018312564A1 (en) * 2017-08-01 2020-01-30 Amgen Inc. Systems and methods for performing a real-time glycan assay of a sample
MA49757A (fr) * 2017-08-01 2020-06-10 Amgen Inc Systèmes et procédés de préparation en temps réel d'un échantillon de polypeptide pour analyse par spectrométrie de masse
WO2021112925A1 (en) 2019-12-06 2021-06-10 Regeneron Pharmaceuticals, Inc. Anti-vegf protein compositions and methods for producing the same
CN115078728A (zh) * 2021-03-11 2022-09-20 盛禾(中国)生物制药有限公司 一种融合蛋白的快速分析方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1587408A4 (en) * 2002-12-20 2007-09-05 Momenta Pharmaceuticals Inc GLYCAN MARKER FOR DIAGNOSIS AND MONITORING OF DISEASES
KR20080032065A (ko) * 2005-06-03 2008-04-14 제넨테크, 인크. 푸코실화 수준이 조절된 항체의 생성 방법
CN101313216A (zh) * 2005-09-22 2008-11-26 普洛茨股份有限公司 酵母突变体中产生的糖基化多肽及其使用方法

Also Published As

Publication number Publication date
CA2697091A1 (en) 2009-03-05
TW200916585A (en) 2009-04-16
RU2010112236A (ru) 2011-10-10
JP2010536355A (ja) 2010-12-02
KR20100038235A (ko) 2010-04-13
CN101784670A (zh) 2010-07-21
AU2008291358A1 (en) 2009-03-05
EP2188382A1 (en) 2010-05-26
US20110117601A1 (en) 2011-05-19
IL202566A0 (en) 2010-06-30
WO2009027041A1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
BRPI0815889A2 (pt) Análise do perfil de glicosilação.
BRPI0722004A2 (pt) Posto de saúde.
NL1034256A1 (nl) Spectroscopiesysteem.
FR2909834B1 (fr) Andaineuse transversale.
FR2890405B1 (fr) Profile de construction
FR2914939B1 (fr) Arret de vantail.
ITBO20060602A1 (it) Profilato estruso.
UA13194S (uk) Профіль
UA13195S (uk) Профіль
UA14551S (uk) Профіль
UA13197S (uk) Профіль
UA14552S (uk) Профіль
UA14574S (uk) Профіль
UA15803S (uk) Профіль
UA15802S (uk) Профіль
UA15801S (uk) Профіль
UA15800S (uk) Профіль
UA14575S (uk) Профіль
UA15799S (uk) Профіль
UA15798S (uk) Профіль
UA15797S (uk) Профіль
UA15796S (uk) Профіль
UA15795S (uk) Профіль
UA15794S (uk) Профіль
UA15793S (uk) Профіль

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]